<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2020.84006</article-id><article-id pub-id-type="publisher-id">JBM-99511</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  The Potential Sources of Transmitting of Hospital Acquired Infection by Routine Devices in Adult ICU in Alrass General Hospital
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Reem</surname><given-names>Dbas Alharbi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Amal</surname><given-names>Hussain Mohammed Ali</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahmad</surname><given-names>Almatroudi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Shaimaa</surname><given-names>Mohamed</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Alrass General Hospital, Qassim Health Cluster, Saudi Ministry of Health, Qassim, KSA</addr-line></aff><aff id="aff1"><addr-line>Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Qassim, KSA</addr-line></aff><pub-date pub-type="epub"><day>26</day><month>03</month><year>2020</year></pub-date><volume>08</volume><issue>04</issue><fpage>69</fpage><lpage>80</lpage><history><date date-type="received"><day>22,</day>	<month>December</month>	<year>2019</year></date><date date-type="rev-recd"><day>12,</day>	<month>April</month>	<year>2020</year>	</date><date date-type="accepted"><day>15,</day>	<month>April</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Hospital-acquired infections (HAI) reflect as a major global safety concern for both patients and health-care professionals. These infections could be in the form of cross-infection, endogenous infection and environmental Infection. Over 80% of these infections are related to devices’ utilization needed for patients’ life support. Methods show this is an observational and cross-sectional study, to identify the microorganism and determine the potential source of transmitting of hospital acquired infection by routine devices in adult ICU. The samples were collected using Amies transport media; three swabs were taken from the surfaces of indwelling urinary catheter, mechanical ventilation device and central venous catheter used from every twelve patients. The samples were cultured and analyzed by using microbiologic technique. Finally, all samples analyzed by MicroScan WalkAway 96 pulse. Results showing the most bacteria isolated are “
  <em>Klebsiella pneumonia</em>” (18.37%), “
  <em>Acinetobacter baumannii</em>” (11.48%), “
  <em>Staphylococcus epidermidis</em>” (4.59%), “
  <em>Staphylococcus haemolyticus</em>” (4.59%), “
  <em>E. coli</em>” (4.59%), “
  <em>Serratia marcescens</em>” (2.3%), “
  <em>Pseudomonas luteola</em>” (2.3%), “
  <em>Kocurio kristinae</em>” (2.3%) and “
  <em>Photorhabdus luminscens</em>” (2.3%). This study detects a high contamination of routine devices and resistant organisms. In the end it is recommended that effective infection control practices and effective strategies to control antibiotic-resistant bacteria should be applied.
 
</p></abstract><kwd-group><kwd>Health-Acquired Infection</kwd><kwd> ICU</kwd><kwd> Devices</kwd><kwd> Catheters</kwd><kwd> Mechanical Ventilator Device</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Hospital acquired infection (HAI) also refers to nosocomial infections that are acquired from hospitalist patients who are admitted to the hospital for any reason other than the infections. The first infection appeared after 48 hours of hospital admission or within 30 days after the patient discharge [<xref ref-type="bibr" rid="scirp.99511-ref1">1</xref>]. Hospital acquired infections reflect as a major global safety concern for both patients and health-care professionals [<xref ref-type="bibr" rid="scirp.99511-ref2">2</xref>]. These infections could be the form of cross-infection, endogenous infection or environmental Infection [<xref ref-type="bibr" rid="scirp.99511-ref1">1</xref>].</p><p>The respiratory system and urinary system are the most systems which might be involved by these infections and around 80% - 87% of hospital acquired infections (HCAIs(: “S. aureus”, “Enterococcus species” (e.g. Faecalis, Faecium), “E. coli”, “coagulase-negative Staphylococci”, “Candida species” (e.g. Albicans, Glabrata), “K. pneumoniae” and “Klebsiella oxytoca”, “P. aeruginosa”, “A. baumannii”, “Enterobacter species”, “Proteus species”, Yeast NOS, Bacteroides species [<xref ref-type="bibr" rid="scirp.99511-ref2">2</xref>]. According to the Centers for Disease Control (CDC) and Prevention in the USA about 1.7 million hospitalized patients annually acquire HAI while being treated for other health issues and that more than 98,000 of these patients die due to the Hospital acquired infection (HAI) [<xref ref-type="bibr" rid="scirp.99511-ref3">3</xref>].</p><p>There are many factors can increase the risk of HAI including older age, immunosuppression, longer hospital stays, multiple underlying chronic illnesses. However, nearly 20% of all nosocomial infections occur in the intensive care unit [<xref ref-type="bibr" rid="scirp.99511-ref4">4</xref>]. Most of these infections (over 80%) are related to devices’ utilization needed for patients’ life support as ventilator-associated bloodstream infection (BSI), surgical site infection (SSI), and urinary tract infection (UTI) [<xref ref-type="bibr" rid="scirp.99511-ref5">5</xref>]. The increase of both morbidity and mortality related to hospital acquired infections in the intensive care unit (ICU) is a matter of serious problem. For that we hope this study helps to increase awareness of HAI.</p><sec id="s1_1"><title>1.1. Research Question</title><p>What are the potential sources of transmitting hospital acquired infections by routine devices in adult ICU in Alrass General Hospital?</p></sec><sec id="s1_2"><title>1.2. Research Objectives</title><sec id="s1_2_1"><title>1.2.1. General Objective</title><p>To determine the potential sources of transmitting hospital acquired infection by routine devises in adult ICU in Alrass General Hospital.</p></sec><sec id="s1_2_2"><title>1.2.2. Specific Objectives</title><p>1) Collect 3 swabs from each patient from three different devices including: indwelling urinary catheter, mechanical ventilation device and central venous catheter.</p><p>2) Culture these swabs in blood agar and MacConkey agar.</p><p>3) Identify microorganisms by performing routine microbiological methods, such as gram stain, colony morphology and standard biochemical tests.</p><p>4) Determine the most source contaminated with pathogenic microorganisms.</p></sec></sec></sec><sec id="s2"><title>2. Methodology</title><sec id="s2_1"><title>2.1. Study Design</title><p>This is an observational and cross-sectional study, to identify the microorganism and determine the potential source of transmitting of hospital-acquired infection by routine devices in adult ICU in Alrass General Hospital. The study was conducted during the time period of October to November (2019).</p></sec><sec id="s2_2"><title>2.2. Conceptual Model of Study</title><disp-formula id="scirp.99511-formula1"><graphic  xlink:href="//html.scirp.org/file/6-2150947x2.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2_3"><title>2.3. Materials and Methods</title><p>The samples obtained from adult ICU (Intensive care unit) at Alrass General Hospital. Three swabs were taken from the surfaces of an indwelling urinary catheter, mechanical ventilation device and central venous catheter used by every twelve patients in ICU. Other samples are taken per week during October (2019) in the morning period from 10:30-11:30 AM after the cleaning from three patents. The total sample size of swabs is 36.</p><sec id="s2_3_1"><title>2.3.1. Isolations of Microorganisms</title><p>All swabs were collected by using Amies transport media. Swabs are immediately transported to the laboratory in the same hospital, and streaked on tow media; Blood agar and MacConkey at 37˚C for 24 hrs for colony isolation and morphological identification.</p></sec><sec id="s2_3_2"><title>2.3.2. Identification of Organisms</title><p>The bacteria isolated and determined by colony morphology with gram-stain. According to gram stain results standard biochemical tests were performed like coagulase, catalase and oxidized [<xref ref-type="bibr" rid="scirp.99511-ref6">6</xref>].</p></sec><sec id="s2_3_3"><title>2.3.3. MicroScan WalkAway 96 Pulse</title><p>Finally, all samples analyzed by MicroScan WalkAway96 pulse, for further identifications.</p><p>MicroScan WalkAway 96 pulse is an automated system which incubates microtiter identification and antimicrobial susceptibility testing panels, interprets biochemical results through the use of a photometric or ﬂuorogenic reader, and generates computerized reports.</p></sec></sec></sec><sec id="s3"><title>3. Ethical Considerations</title><p>Ethical approved for this study was obtained from the Regional research ethics Committee of medical education for the research in Alrass Hospital. And also, from the research Revie committee of college of applied medical science, department of medical laboratories in Qassim University.</p><sec id="s3_1"><title>3.1. Inclusions Criteria</title><p>Any adult patients in intensive care unit for more than two days.</p></sec><sec id="s3_2"><title>3.2. Exclusions Criteria</title><p>Patients outside the intensive care unit.</p></sec><sec id="s3_3"><title>3.3. Data Analysis Plan</title><p>Data was entered and analyzed using Microsoft Excel Software. The results were interpreted and presented in Microsoft Word Software using figures, tables and graphs.</p></sec><sec id="s3_4"><title>3.4. Study Limitations</title><p>The study was performed on local hospital and samples size Equal thirty-six.</p></sec></sec><sec id="s4"><title>4. Results</title><p>Total of thirty-six swabs were collected from three different devices used by every twelve patients in ICU (Intensive care unit). Bacteria were growth on nineteen plates (52.8%) and six was non-significant count (16.7%). The remaining swabs showed non-bacterial growth (30.5%) From these swabs, nine bacteria were isolated. These organisms include “Klebsiella pneumoniae”, “Acinetobacter baumannii”, “Staphylococcus epidermidis”, “Staphylococcus epidermidis”, “Staphylococcus haemolyticus”, “Escherichia coli”, “Serratia marcescens”, “Pseudomonas luteola”, “Kocurio kristinae” and “Photorhabdus luminscens”.</p><p>The most bacteria isolated were “Klebsiella pneumoniae” (18.37%), “Acinetobacter baumannii” (11.48%), “Staphylococcus epidermidis” (4.59%), “Staphylococcus haemolyticus” (4.59%), “E. coli” (4.59%), “sErratia marcescens” (2.3%), “Pseudomonas luteola” (2.3%), “Kocurio kristinae” (2.3%) and “Photorhabdus luminscens” (2.3%) as shown in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>Total sample: 36 samples, Positive samples: 19 samples.</p><p>Proportion of positive samples: 19\36 &#215; 100 = 52.8%.</p><p><xref ref-type="table" rid="table2">Table 2</xref> shows that the number of bacteria isolated from the three routine devices used by every twelve patients in ICU. Anyway, the most bacteria isolated were “Klebsiella pneumoniae” followed by “Acinetobacter-baumannii”.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> The percentage of bacteria species found in this study</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Percentage</th><th align="center" valign="middle" >Number of isolations</th><th align="center" valign="middle" >Bacterial type</th></tr></thead><tr><td align="center" valign="middle" >18.37%</td><td align="center" valign="middle" >8 samples</td><td align="center" valign="middle" >Klebsiella pneumoniae</td></tr><tr><td align="center" valign="middle" >11.48%</td><td align="center" valign="middle" >5 samples</td><td align="center" valign="middle" >Acinetobacter baumannii</td></tr><tr><td align="center" valign="middle" >4.59%</td><td align="center" valign="middle" >2 samples</td><td align="center" valign="middle" >Staphylococcus epidermidis</td></tr><tr><td align="center" valign="middle" >4.59%</td><td align="center" valign="middle" >2 samples</td><td align="center" valign="middle" >Staphylococcus haemolyticus</td></tr><tr><td align="center" valign="middle" >4.59%</td><td align="center" valign="middle" >2 samples</td><td align="center" valign="middle" >E. coli</td></tr><tr><td align="center" valign="middle" >2.3%</td><td align="center" valign="middle" >1 sample</td><td align="center" valign="middle" >Serratia marcescens</td></tr><tr><td align="center" valign="middle" >2.3%</td><td align="center" valign="middle" >1 sample</td><td align="center" valign="middle" >Pseudomonas luteola</td></tr><tr><td align="center" valign="middle" >2.3%</td><td align="center" valign="middle" >1 sample</td><td align="center" valign="middle" >Kocurio kristinae</td></tr><tr><td align="center" valign="middle" >2.3%</td><td align="center" valign="middle" >1 sample</td><td align="center" valign="middle" >Photorhabdus luminscens</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> The isolated bacteria found in routine devices among 12 patients in ICU (intensive care unit)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Patients number</th><th align="center" valign="middle" >Mechanical ventilator device</th><th align="center" valign="middle" >Indwelling urinary catheter</th><th align="center" valign="middle" >Central venous catheter</th></tr></thead><tr><td align="center" valign="middle" >P1</td><td align="center" valign="middle" >Non-significant count</td><td align="center" valign="middle" >1) Staphylococcus haemolytic 2) Klebsiella pneumoniae</td><td align="center" valign="middle" >No growth</td></tr><tr><td align="center" valign="middle" >P2</td><td align="center" valign="middle" >Photorhabdus luminscens</td><td align="center" valign="middle" >1) Staphylococcus epidermidis 2) Pseudomonas luteola</td><td align="center" valign="middle" >Non significant count</td></tr><tr><td align="center" valign="middle" >P3</td><td align="center" valign="middle" >1) Acinetobacter baumannii complex haemolytic 2) Klebsiella pneumoniae</td><td align="center" valign="middle" >1) Acinetobacter baumannii complex haemolytic 2) Klebsiella pneumoniae</td><td align="center" valign="middle" >Kocurio kristinae</td></tr><tr><td align="center" valign="middle" >P4</td><td align="center" valign="middle" >Serratia-marcescens</td><td align="center" valign="middle" >Klebsiella-pneumoniae</td><td align="center" valign="middle" >No growth</td></tr><tr><td align="center" valign="middle" >P5</td><td align="center" valign="middle" >Staphylococcus epidermidis</td><td align="center" valign="middle" >Non significant count</td><td align="center" valign="middle" >No growth</td></tr><tr><td align="center" valign="middle" >P6</td><td align="center" valign="middle" >No growth</td><td align="center" valign="middle" >Acinetobacter-baumannii complex haemolytic</td><td align="center" valign="middle" >No growth</td></tr><tr><td align="center" valign="middle" >P7</td><td align="center" valign="middle" >Klebsiella pneumoniae</td><td align="center" valign="middle" >No growth</td><td align="center" valign="middle" >No growth</td></tr><tr><td align="center" valign="middle" >P8</td><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >Escherichia coli</td><td align="center" valign="middle" >No growth</td></tr><tr><td align="center" valign="middle" >P9</td><td align="center" valign="middle" >Klebsiella pneumoniae</td><td align="center" valign="middle" >Non significant count</td><td align="center" valign="middle" >No growth</td></tr><tr><td align="center" valign="middle" >P10</td><td align="center" valign="middle" >No growth</td><td align="center" valign="middle" >Staphylococcus haemolytic</td><td align="center" valign="middle" >Non significant count</td></tr><tr><td align="center" valign="middle" >P11</td><td align="center" valign="middle" >Acinetobacter-baumannii complex haemolytic</td><td align="center" valign="middle" >Acinetobacter-baumannii complex haemolytic</td><td align="center" valign="middle" >No growth</td></tr><tr><td align="center" valign="middle" >P12</td><td align="center" valign="middle" >Klebsiella-pneumoniae</td><td align="center" valign="middle" >Klebsiella pneumoniae</td><td align="center" valign="middle" >Non significant count</td></tr></tbody></table></table-wrap><p><xref ref-type="fig" rid="fig1">Figure 1</xref> shows that the indwelling urinary catheter was most contaminated device, twelve bacteria were isolated from nine swabs (75%), tow swabs were non-significant count (16.7%), and only one swab was no growth (8.3%). Following by mechanical ventilator device, nine bacteria were isolated from nine</p><p>swabs (75%), one swab was non-significant count (16.7%), and tow swabs were no growth (8.3%). Finally, the least contamination device was the central venous catheter with only one swab with significant growth (8.3%).</p><p><xref ref-type="fig" rid="fig2">Figure 2</xref> shows that the “Klebsiella pneumonia” was most isolated bacteria on mechanical ventilation device (30%), followed by “Acinetobacter baumannii” (15%), “Staphylococcus epidermidis” (7.5%), “E. coli” (7.5%), “Serratia marcescens” (7.5%), “Photorhabdus luminscens” (7.5%).</p><p><xref ref-type="fig" rid="fig3">Figure 3</xref> shows that the Klebsiella pneumonia was most isolated bacteria (27.7%), followed by “Acinetobacter baumannii” (20.45%), “Staphylococcushaemolyticus” (13.64%), “Staphylococcus epidermidis” (6.80%), “E. coli” (6.80%), “Pseudomonas luteola” (6.80%).</p><p><xref ref-type="fig" rid="fig4">Figure 4</xref> shows that, most swabs taken from CVC (central venous catheter) was negative (no growth) (67%), and about 25% was gram positive non-significant count bacteria. Overall, one swab found to be significantly contaminated with “Kocurio kristinae” (8%).</p><p><xref ref-type="table" rid="table3">Table 3</xref> shows that the Enterobacteriaceae species resistance rate to Trimeth\sulfa, Ceftazidime, Ciprofloxacin were 90%, about 70% were resistant to Amp\sulbactam, Imipenem, Pip\tazo and 60% were resistant to Amikacin. On the other hand, Acinetobacter baumannii resistance rate to Ceftazidime, Ciprofloxacin, Imipenem, Pip\tazoand Amikacin was 100%, and about 80% to Trimethyl\sulfa.</p></sec><sec id="s5"><title>5. Discussion</title><p>The incidence of hospital acquired infections varies according to the type of hospital and Intensive Care Unit (ICU), the patient population and surveillance techniques used to detect a hospital acquired infection [<xref ref-type="bibr" rid="scirp.99511-ref7">7</xref>]. In each hundred hospitalized patients seven of them inadvanced countries and ten of them in developing countries can acquire one of the health associated infections. Overall, most populations under the risk are patients in Intensive Care Units (ICUs), burn units, organ transplant unit and neonate’s unit [<xref ref-type="bibr" rid="scirp.99511-ref8">8</xref>].</p><p>There are a large number of microorganisms are responsible for hospital acquired infections and any microbe may have the ability to causes infection in hospitalized patients. However, ninety percent of the HAI (Hospital Acquired Infection) is caused by bacteria, whereas viral, fungal, protozoal are less commonly involved [<xref ref-type="bibr" rid="scirp.99511-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.99511-ref9">9</xref>].</p><p>Depending on Extended Prevalence of Infection in Intensive Care (EPIC II) study, the proportion of infected patients within the intensive care unit (ICU) are often as high as 51%, and the most frequently reported sites for ICU acquired infections were the lungs (64%), abdominal (19%), and bloodstream (15%) [<xref ref-type="bibr" rid="scirp.99511-ref10">10</xref>].</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Resistance pattern of most isolated bacteria found in the routine devices against different type antibiotics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Bacteria</th><th align="center" valign="middle" >Antibiotic used</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle"  rowspan="7"  >Enterobacteriaceae</td><td align="center" valign="middle" >Amp\sulbactam</td><td align="center" valign="middle" >70%</td></tr><tr><td align="center" valign="middle" >Ceftazidime</td><td align="center" valign="middle" >90%</td></tr><tr><td align="center" valign="middle" >Amikacin</td><td align="center" valign="middle" >60%</td></tr><tr><td align="center" valign="middle" >Ciprofloxacin</td><td align="center" valign="middle" >90%</td></tr><tr><td align="center" valign="middle" >Imipenem</td><td align="center" valign="middle" >70%</td></tr><tr><td align="center" valign="middle" >Pip\tazo</td><td align="center" valign="middle" >70%</td></tr><tr><td align="center" valign="middle" >Trimeth\sulfa</td><td align="center" valign="middle" >90%</td></tr><tr><td align="center" valign="middle"  rowspan="7"  >Acinetobacter baumannii</td><td align="center" valign="middle" >Amp\sulbactam</td><td align="center" valign="middle" >100%</td></tr><tr><td align="center" valign="middle" >Ceftazidime</td><td align="center" valign="middle" >100%</td></tr><tr><td align="center" valign="middle" >Amikacin</td><td align="center" valign="middle" >100%</td></tr><tr><td align="center" valign="middle" >Ciprofloxacin</td><td align="center" valign="middle" >100%</td></tr><tr><td align="center" valign="middle" >Imipenem</td><td align="center" valign="middle" >100%</td></tr><tr><td align="center" valign="middle" >Pip\tazo</td><td align="center" valign="middle" >100%</td></tr><tr><td align="center" valign="middle" >Trimeth\sulfa</td><td align="center" valign="middle" >80%</td></tr></tbody></table></table-wrap><p>The most common organisms cause ICU-acquired infections are “Enterobacteriaceae” (20%), “S. aureus (20%), “Pseudomonas spp.” (17%), “Enterococcus spp.” (10%) and “Acinetobacter spp.” (5%) [<xref ref-type="bibr" rid="scirp.99511-ref11">11</xref>].</p><p>Hospital acquired infections are becoming an increasing problem for hospitalized patients, especially in the ICU, particularly those acquired following the insertion of devices [<xref ref-type="bibr" rid="scirp.99511-ref12">12</xref>]. Anyway, according to the CDC’s National Nosocomial Infections Surveillance (NNIS) system criteria, the three common Device-associated infections are catheter-associated urinary tract infection (CA-UTI), IV catheter-related bloodstream infection (IV-CRBSI), and ventilator-associated pneumonia (VAP) [<xref ref-type="bibr" rid="scirp.99511-ref12">12</xref>].</p><p>In Alrass General Hospital, all nurses and staff followed Centers for Disease Control and Prevention (CDC) guideline for preventing a device-associated health-acquired infection. In ICU, cleaning and disinfection are run every morning. However, result of contamination devices in this study shows that, in a total of thirty-six swabs from the three devices, bacteria were grown on 19 plates (52.8%) and 6 were non-significant count (16.7%). The remaining swabs showed no bacterial growth (30.5%).</p><p>In our study the most organism founded was members of the “Enterobacteriaceae family”, such as “Escherichia coli”, “Klebsiella pneumoniae” and “Serratia marcescens”, followed by “Acinetobacter baumannii” and “Coagulase-negative staphylococci”. According to CDC these bacteria were reported as common bacteria that cause hospital-acquired infections [<xref ref-type="bibr" rid="scirp.99511-ref11">11</xref>].</p><p>Depending on the data of the infection control department in Alrass General Hospital, in the period from January to October (2019) there were 16 cases of hospital acquired infection in ICU. The most causative bacteria were “Klebsiella pneumoniae” in four cases (25%), “Acinetobacter baumannii” in three cases (18.75%), “Serratia marcescens” in three cases (18.75%), and one case of “Staphylococcus haemolyticus” (6.25%), “Staphylococcus aureaus” (6.25%), “Protous mirabilis” (6.25%), “Pseudomonas stutzeri” (6.25%), “Klebsiella oxytoca” (6.25%).</p><p>During this period central line-associated blood stream infections (CLABSI) was most common device-associated infections, following by ventilator-associated pneumonia (VAP) then catheter-associated urinary tract infections (CAUTI), these results differ from Al-Tawfiq et al. study, which was the catheter-associated urinary tract infections the most common [<xref ref-type="bibr" rid="scirp.99511-ref13">13</xref>].</p><p>In our study the most bacteria isolated were “Klebsiella pneumoniae” followed by “Acinetobacter”. These results are correlated with most causative organisms reported by infection control department in Alrass General Hospital.</p><p>Tao L et al. found that the most organism isolated from a patient with devices associated infections were “Acinetobacter baumannii” (19.1%), followed by “Pseudomonas aeruginosa” (17.2%) and “Klebsiella pneumoniae” (11.9%), these results slightly resemble to our finding [<xref ref-type="bibr" rid="scirp.99511-ref14">14</xref>].</p><p>Our finding is consistent with a result of a study performed on Brazilian hospitals to measure the device-associated infection, the “Enterobacteriaceae” were the most isolated bacteria and “Acinetobacter spp.” and “Coagulase-negative staphylococci” (8.4%) were also significant [<xref ref-type="bibr" rid="scirp.99511-ref15">15</xref>]. Weinstein, R et al. reported that the gram-negative bacilli were associated with 23.8% of blood stream infections (BSIs), 65.2% of pneumonia episodes, 33.8% of surgical site infections (SSIs), and 71.1% of urinary tract infections (UTIs) [<xref ref-type="bibr" rid="scirp.99511-ref16">16</xref>].</p><p>In our study the indwelling urinary catheters were the most contamination device, they were significantly contaminated with “Klebsiella pneumonia” (27.27%), which slightly resemble the result of Nicolle, L [<xref ref-type="bibr" rid="scirp.99511-ref17">17</xref>].</p><p>Mechanical ventilator devices were the second most contamination device, the most microorganisms found are gram-negative bacilli (67.5%), followed by coagulase-negative staphylococci (7.5%), the result looks like to most bacteria isolated from ventilator-associated pneumonia patients in Weinstein R et al. study which found gram-negative bacilli 58% [<xref ref-type="bibr" rid="scirp.99511-ref15">15</xref>].</p><p>The resistance patterns of organisms isolated in the present study are compared with those reported by Cuellar L. et al. and Afhami S. et al. studies, in our study the Enterobacteriaceae resistance to Ceftazidime and Pip\tazoaremore than that in Cuellar L. et al. study and Acinetobacter strains resistance to ceftazidime and Amp\sulbactam are more than that in Afhami S. et al. study [<xref ref-type="bibr" rid="scirp.99511-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.99511-ref18">18</xref>].</p><sec id="s5_1"><title>5.1. Prevention and Control of Hospital Acquired Infections</title><p>Hospital acquired infections can be controlled by practicing infection control programs, keep a check on antimicrobial use and its resistance and adopting antibiotic control policy. An efficient surveillance system guided by the World Health Organization (WHO) can help healthcare institutes to devise infection control programs [<xref ref-type="bibr" rid="scirp.99511-ref8">8</xref>]. All health workers are responsible, they must work together to reduce the risk of infection for patients and staff. However, Infection control programs are cost-effective, but their application is often hindered by an absence of support from administrators and poor compliance by doctors, nurses, and other health workers [<xref ref-type="bibr" rid="scirp.99511-ref19">19</xref>].</p></sec><sec id="s5_2"><title>5.2. Central Line-Associated Blood Stream Infections Prevention</title><p>Center for Disease Control and Prevention (CDC) identified Strategies for prevention of ClBSI which includes the following:</p><p>1) Educating and training health care providers who insert and maintain catheters.</p><p>2) Using maximal sterile barrier precautions during CVC insertion.</p><p>3) Using a 2% chlorhexidine preparation for skin antisepsis.</p><p>4) Avoiding routine replacement of CVCs as a strategy to prevent infection.</p><p>5) Using antiseptic/antibiotic-impregnated short-term CVCs if the rate of infection is high despite adherence to other strategies [<xref ref-type="bibr" rid="scirp.99511-ref20">20</xref>].</p></sec><sec id="s5_3"><title>5.3. Catheter-Associated Urinary Tract Infection</title><p>The strategies for the prevention of CAUTI are divided into basic practices of insertion, maintenance, and removal. In insertion, the medical staff assess for medical necessity and appropriateness of device, use aseptic insertion technique and sterile supplies and apply securement device to prevent movement and traction. The next step is maintenance which includes the hands preserve sterile, continuous closed system and regularly empty drain bag by using a patient-dedicated collection container. Finally, remove it when no longer medically necessary [<xref ref-type="bibr" rid="scirp.99511-ref21">21</xref>].</p></sec><sec id="s5_4"><title>5.4. Ventilator-Associated Pneumonia (VAP) Prevention</title><p>CDC recommendation practices for prevention of VAP including the following:</p><p>1) No routine changing of humidified ventilator circuits.</p><p>2) Periodically draining and discarding condensate collecting in the ventilator tubing.</p><p>3) Changing the heat-and-moisture exchangers when they malfunction mechanically become visibly soiled [<xref ref-type="bibr" rid="scirp.99511-ref22">22</xref>].</p></sec></sec><sec id="s6"><title>6. Conclusion</title><p>This study detects a high contamination of routine devices and resistant organisms and appropriate interventions are necessary to reduce these rates. Indwelling urinary catheters were the most contaminated devices followed by mechanical ventilator devices; the less one was central venous catheters. The most organisms isolated resemble those reported by the infection control in Alrass General Hospital as the most curative organism of HAI. Depending on these results we suggest that the routine devices used in intensive care unit in Alrass General Hospital may consider as a source of transmitting of HAI.</p></sec><sec id="s7"><title>Recommendations</title><p>1) Effective infection control practices and effective strategies to control antibiotic-resistant bacteria should be applied.</p><p>2) Recommend more surveillance system guided by WHO in KSA hospitals。</p><p>3) Recommended more researches on HAI in the Middle East.</p></sec><sec id="s8"><title>Acknowledgements</title><p>I would like to thank the staff and management of Alrass General Hospital, especially the infection control department and staff of the Microbiology Laboratory for space and their help to undertake this study. I would also like to extend my appreciation to the ICU nurses and to Dr. Amal Sulaiman and Dr. Sara Aliin Qassim University—Microbiology Department.</p></sec><sec id="s9"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s10"><title>Cite this paper</title><p>Alharbi, R.D., Ali, A.H.M., Almatroudi, A. and Mohamed, S. (2020) The Potential Sources of Transmitting of Hospital Acquired Infection by Routine Devices in Adult ICU in Alrass General Hospital. Journal of Biosciences and Medicines, 8, 69-80. https://doi.org/10.4236/jbm.2020.84006</p></sec></body><back><ref-list><title>References</title><ref id="scirp.99511-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Tagoe, D., Baidoo, S., Dadzie, I., Tengey, D. and Agede, C. (2011) Potential Sources of Transmission of Hospital Acquired Infections in the Volta Regional Hospital in Ghana. Ghana Medical Journal, 45, 22-26. https://doi.org/10.4314/gmj.v45i1.68918</mixed-citation></ref><ref id="scirp.99511-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Haque, M., Sartelli, M., McKimm, J. and Abu Bakar, M. (2018) Health Care-Associated Infections and Ash: An Overview. Infection and Drug Resistance, 11, 2321-2333. https://doi.org/10.2147/IDR.S177247</mixed-citation></ref><ref id="scirp.99511-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Cimiotti, J.P., Aiken, L.H., Sloane, D.M. and Wu, E.S. (2012) Nurse Staffing, Burnout, and Health Care-Associated Infection. American Journal of Infection Control, 40, 486-490.https://doi.org/10.1016/j.ajic.2012.02.029</mixed-citation></ref><ref id="scirp.99511-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Monegro, A.F. and Regunath, H. (2018) Hospital Acquired Infections. StatPearls Publishing.</mixed-citation></ref><ref id="scirp.99511-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Corona, A. and Raimondi, F. (2004) Prevention of Nosocomial Infection in the ICU Setting. Minerva Anestesiologica, 70, 329-337.</mixed-citation></ref><ref id="scirp.99511-ref6"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Akhtar</surname><given-names> N. </given-names></name>,<etal>et al</etal>. (<year>2010</year>)<article-title>Hospital Acquired Infections in a Medical Intensive Care Unit</article-title><source> Journal of College of Physicians and Surgeons Pakistan</source><volume> 20</volume>,<fpage> 386</fpage>-<lpage>390</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.99511-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Zra, A., Dasgupta, S., Das, S. and Chawan, N. (2015) Nosocomial Infections in the Intensive Care Unit: Incidence, Risk Factors, Outcome and Associated Pathogens in a Public Tertiary Teaching Hospital of Eastern India. Indian Journal of Critical Care Medicine, 19, 14-20. https://doi.org/10.4103/0972-5229.148633</mixed-citation></ref><ref id="scirp.99511-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Khan, H., Baig, F. and Mehboob, R. (2017) Nosocomial Infections: Epidemiology, Prevention, Control and Surveillance. Asian Pacific Journal of Tropical Biomedicine, 7, 478-482. https://doi.org/10.1016/j.apjtb.2017.01.019</mixed-citation></ref><ref id="scirp.99511-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Bereket, W., Hemalatha, K., Getenet, B., Wondwossen, T., Solomon, A., Zeynudin, A. and Kannan, S. (2012) Update on Bacterial Nosocomial Infections. European Review for Medical and Pharmacological Sciences, 16, 1039-1044.</mixed-citation></ref><ref id="scirp.99511-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Viencent, J., Marshall, L., Silva, E., Anzueto, A., Martin, C., Moreno, R., et al. (2009) International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA, 302, 2323-2329. https://doi.org/10.1001/jama.2009.1754</mixed-citation></ref><ref id="scirp.99511-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Afhami, S., Seifi, A., Hajiabdolbaghi, M., Bazaz, N.E., Hadadi, A., Hasibi, M., et al. (2019) Assessment of Device-Associated Infection Rates in Four Teaching Hospitals in Islamic Republic of Iran. Eastern Mediterranean Health Journal, 25, 90-97. https://doi.org/10.26719/emhj.18.015</mixed-citation></ref><ref id="scirp.99511-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Sallam, S.A., Arafa, M.A., Razek, A.A., Naga, M. and Hamid, M.A. (2005) Device-Related Nosocomial Infection in Intensive Care Units of Alexandria University Students Hospital. Eastern Mediterranean Health Journal, 11, 52-61.</mixed-citation></ref><ref id="scirp.99511-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Al-Tawfiq, J.A., Amalraj, A. and Memish, Z.A. (2013) Reduction and Surveillance of Device-Associated Infections in Adult Intensive Care Units at a Saudi Arabian Hospital, 2004-2011. International Journal of Infectious Diseases, 17, e1207-e1211.https://doi.org/10.1016/j.ijid.2013.06.015</mixed-citation></ref><ref id="scirp.99511-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Tao, L., Hu, B., Rosenthal, V.D., Gao, X. and He, L. (2011) Device-Associated Infection Rates in 398 Intensive Care Units in Shanghai, China: International Nosocomial Infection Control Consortium (INICC) Findings. International Journal of Infectious Diseases, 15, e774-e780. https://doi.org/10.1016/j.ijid.2011.06.009</mixed-citation></ref><ref id="scirp.99511-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Salomao, R., Rosenthal, V.D., Grimberg, G., Nouer, S., Blecher, S., Buchner-Ferreira, S. and Maretti-da-Silva, M.A. (2008) Device-Associated Infection Rates in Intensive Care Units of Brazilian Hospitals: Findings of the International Nosocomial Infection Control Consortium. Pan American Journal of Public Health, 24. https://doi.org/10.1590/S1020-49892008000900006</mixed-citation></ref><ref id="scirp.99511-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Weinstein, R.A., Gaynes, R., Edwards, J.R. and National Nosocomial Infections Surveillance System (2005) Overview of Nosocomial Infections Caused by Gram-Negative Bacilli. Clinical Infectious Diseases, 41, 848-854. https://doi.org/10.1086/432803</mixed-citation></ref><ref id="scirp.99511-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Nicolle, L.E. (2014) Catheter Associated Urinary Tract Infections. Antimicrobial Resistance and Infection Control, 3, 23. https://doi.org/10.1186/2047-2994-3-23</mixed-citation></ref><ref id="scirp.99511-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Cuellar, L.E., Fernandez-Maldonado, E., Rosenthal, V.D., Castaneda-Sabogal, A., Rosales, R., Mayorga-Espichan, M.J., Castillo-Bravo, L.I., et al. (2008) Device-Associated Infection Rates and Mortality in Intensive Care Units of Peruvian Hospitals: Findings of the International Nosocomial Infection Control Consortium. Revista Panamericana de Salud Pública, 24, 16-24.https://doi.org/10.1590/S1020-49892008000700002</mixed-citation></ref><ref id="scirp.99511-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Saloojee, H. and Steenhoff, A. (2001) The Health Professional’s Role in Preventing Nosocomial Infections. Postgraduate Medical Journal, 77, 16-19. https://doi.org/10.1136/pmj.77.903.16</mixed-citation></ref><ref id="scirp.99511-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Miller, D.L. and O’Grady, N.P. (2012) SIR Disclaimer. Journal of Vascular and Interventional Radiology, 8, 997-1007. https://doi.org/10.1016/j.jvir.2012.04.023</mixed-citation></ref><ref id="scirp.99511-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Septimus, E. and Moody, J. (2016) Prevention of Device-Related Healthcare-Associated Infections. F1000Research, 5, 65. https://doi.org/10.12688/f1000research.7493.1</mixed-citation></ref><ref id="scirp.99511-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Misset, B., Timsit, J., Dumay, M., Garrouste, M., Chalfine, A., Flouriot, I., Goldstein, F. and Carlet, J. (2004) A Continuous Quality-Improvement Program Reduces Nosocomial Infection Rates in the ICU. Intensive Care Medicine, 30, 395-400. https://doi.org/10.1007/s00134-003-2096-1</mixed-citation></ref></ref-list></back></article>